Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response
出版年份 2022 全文链接
标题
Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response
作者
关键词
-
出版物
PHARMACOLOGY & THERAPEUTICS
Volume 236, Issue -, Pages 108108
出版商
Elsevier BV
发表日期
2022-01-07
DOI
10.1016/j.pharmthera.2022.108108
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer
- (2021) Hope S. Rugo et al. JAMA Oncology
- Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
- (2021) Aditya Bardia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synergistic Platinum(II) Prodrug Nanoparticles for Enhanced Breast Cancer Therapy
- (2020) Chen-Xi Yang et al. MOLECULAR PHARMACEUTICS
- Novel drug combination nanoparticles exhibit enhanced plasma exposure and dose-responsive effects on eliminating breast cancer lung metastasis
- (2020) Qingxin Mu et al. PLoS One
- Advances in liposomal drug delivery to cancer: An overview
- (2020) Shivani Saraf et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Synergistic Chemotherapy for Breast Cancer and Breast Cancer Brain Metastases via Paclitaxel-Loaded Oleanolic Acid Nanoparticles
- (2020) Youmei Bao et al. MOLECULAR PHARMACEUTICS
- Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals
- (2020) Gergely Tibor Kozma et al. ADVANCED DRUG DELIVERY REVIEWS
- Controlled solvent removal from antiviral drugs and excipients in solution enables the formation of novel combination multi-drug-motifs in pharmaceutical powders composed of lopinavir, ritonavir and tenofovir
- (2020) Jesse Yu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Novel Long-Acting Drug Combination Nanoparticles Composed of Gemcitabine and Paclitaxel Enhance Localization of Both Drugs in Metastatic Breast Cancer Nodules
- (2020) Jesse Yu et al. PHARMACEUTICAL RESEARCH
- The Therapeutic Efficacy of Dendrimer and Micelle Formulations for Breast Cancer Treatment
- (2020) Sibusiso Alven et al. Pharmaceutics
- Nanomedicines accessible in the market for clinical interventions
- (2020) Vedant Gadekar et al. JOURNAL OF CONTROLLED RELEASE
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Latest Research and Development into the Antibody–Drug Conjugate, [fam-] Trastuzumab Deruxtecan (DS-8201a), for HER2 Cancer Therapy
- (2019) Takashi Nakada et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Molecular Mechanisms of Breast Cancer Metastasis to the Lung: Clinical and Experimental Perspectives
- (2019) Braeden Medeiros et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties
- (2019) Lawrence D Mayer et al. International Journal of Nanomedicine
- Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer
- (2019) Fabrice André et al. NEW ENGLAND JOURNAL OF MEDICINE
- In Vivo Evaluation of Dual-Targeted Nanoparticles Encapsulating Paclitaxel and Everolimus
- (2019) Houdaihed et al. Cancers
- Current status of nanomedicine in the chemotherapy of breast cancer
- (2019) A. I. Fraguas-Sánchez et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Patient-Derived Xenograft Models of Breast Cancer and Their Application
- (2019) Murayama et al. Cells
- The role of liposomes in clinical nanomedicine development. What now? Now what?
- (2019) Daan J.A. Crommelin et al. JOURNAL OF CONTROLLED RELEASE
- Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
- (2019) Rashmi K. Murthy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
- (2019) Shanu Modi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor targeting via EPR: Strategies to enhance patient responses
- (2018) Susanne K. Golombek et al. ADVANCED DRUG DELIVERY REVIEWS
- Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer
- (2018) G N Hortobagyi et al. ANNALS OF ONCOLOGY
- Co-delivery of paclitaxel and gemcitabine by methoxy poly(ethylene glycol)–poly(lactide-coglycolide)-polypeptide nanoparticles for effective breast cancer therapy
- (2018) Shiliang Dong et al. ANTI-CANCER DRUGS
- Breast cancer metastasis through the lympho-vascular system
- (2018) S. David Nathanson et al. CLINICAL & EXPERIMENTAL METASTASIS
- Aromatase inhibitors in premenopausal women with breast cancer: the state of the art and future prospects
- (2018) M. Pistelli et al. Current Oncology
- Translation of combination nanodrugs into nanomedicines: lessons learned and future outlook
- (2018) Qingxin Mu et al. JOURNAL OF DRUG TARGETING
- Long-Acting Profile of 4 Drugs in 1 Anti-HIV Nanosuspension in Nonhuman Primates for 5 Weeks After a Single Subcutaneous Injection
- (2018) Lisa A. McConnachie et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice
- (2018) Ethel R. Pereira et al. SCIENCE
- Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice
- (2018) M. Brown et al. SCIENCE
- Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells
- (2018) Amila K. Nanayakkara et al. Scientific Reports
- Conjugate of PAMAM Dendrimer, Doxorubicin and Monoclonal Antibody—Trastuzumab: The New Approach of a Well-Known Strategy
- (2018) Monika Marcinkowska et al. Polymers
- Extended cell and plasma drug levels after one dose of a 3-in-1 nanosuspension containing lopinavir, efavirenz, and tenofovir in non-human primates
- (2018) Josefin Koehn et al. AIDS
- Three HIV drugs, atazanavir, ritonavir and tenofovir co-formulated in drug-combination nanoparticles exhibit long-acting and lymphocyte targeting properties in non-human primates
- (2018) Simone Perazzolo et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
- (2018) Jennifer K. Litton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics
- (2018) Thomas Vangijzegem et al. Expert Opinion on Drug Delivery
- Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment
- (2018) Jing Zhang et al. MOLECULES
- MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
- (2017) George W. Sledge et al. JOURNAL OF CLINICAL ONCOLOGY
- Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy
- (2017) Jingjing Sun et al. JOURNAL OF CONTROLLED RELEASE
- 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
- (2017) Hongchao Pan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment
- (2017) Maryam Afsharzadeh et al. Artificial Cells Nanomedicine and Biotechnology
- Relationship between Tumor Biomarkers and Efficacy in EMILIA, a Phase III Study of Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer
- (2016) J. Baselga et al. CLINICAL CANCER RESEARCH
- Breast Cancer Epidemiology and Risk Factors
- (2016) KRISTIN ROJAS et al. CLINICAL OBSTETRICS AND GYNECOLOGY
- Genetically engineered mouse models in oncology research and cancer medicine
- (2016) Kelly Kersten et al. EMBO Molecular Medicine
- Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
- (2016) Peng Zhang et al. JOURNAL OF CONTROLLED RELEASE
- In-depth structural characterization of Kadcyla® (ado-trastuzumab emtansine) and its biosimilar candidate
- (2016) Liuxi Chen et al. mAbs
- Palbociclib and Letrozole in Advanced Breast Cancer
- (2016) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- CA4-loaded doxorubicin prodrug coating Fe3O4 nanoparticles for tumor combination therapy
- (2016) Hongmei Liu et al. RSC Advances
- Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice
- (2015) Huan Meng et al. ACS Nano
- Anti-HIV Drug-Combination Nanoparticles Enhance Plasma Drug Exposure Duration as Well as Triple-Drug Combination Levels in Cells Within Lymph Nodes and Blood in Primates
- (2015) Jennifer P. Freeling et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Co-delivery of paclitaxel and gemcitabine via CD44-targeting nanocarriers as a prodrug with synergistic antitumor activity against human biliary cancer
- (2015) Ilkoo Noh et al. BIOMATERIALS
- GEMMs as preclinical models for testing pancreatic cancer therapies
- (2015) Aarthi Gopinathan et al. Disease Models & Mechanisms
- Preclinical studies of dendrimer prodrugs
- (2015) Chie Kojima Expert Opinion on Drug Metabolism & Toxicology
- Chemotherapy for Metastatic Breast Cancer – An Anachronism in the Era of Personalised and Targeted Oncological Therapy?
- (2015) A. Schneeweiss et al. GEBURTSHILFE UND FRAUENHEILKUNDE
- Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
- (2015) Andreas Wicki et al. JOURNAL OF CONTROLLED RELEASE
- Mesoscale Nanoparticles Selectively Target the Renal Proximal Tubule Epithelium
- (2015) Ryan M. Williams et al. NANO LETTERS
- Translational value of mouse models in oncology drug development
- (2015) Stephen E Gould et al. NATURE MEDICINE
- Breast cancer metastasis and the lymphatic system
- (2015) MUNAZZAH RAHMAN et al. Oncology Letters
- Systems Approach to targeted and long-acting HIV/AIDS therapy
- (2015) Rodney J. Y. Ho et al. Drug Delivery and Translational Research
- Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer
- (2015) Alexandra Canonici et al. Oncotarget
- Nanomedicine Scale-up Technologies: Feasibilities and Challenges
- (2014) Rishi Paliwal et al. AAPS PHARMSCITECH
- Trastuzumab emtansine: mechanisms of action and drug resistance
- (2014) Mark Barok et al. BREAST CANCER RESEARCH
- Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling
- (2014) Darren Michael Moss et al. BRITISH JOURNAL OF PHARMACOLOGY
- Trastuzumab Emtansine: A Review of Its Use in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab-Based Therapy
- (2014) Sohita Dhillon DRUGS
- Animal models for exploring the pharmacokinetics of breast cancer therapies
- (2014) Omar M Rashid et al. Expert Opinion on Drug Metabolism & Toxicology
- Colocalized Delivery of Rapamycin and Paclitaxel to Tumors Enhances Synergistic Targeting of the PI3K/Akt/mTOR Pathway
- (2014) Elvin Blanco et al. MOLECULAR THERAPY
- Advances in the chemistry of dendrimers
- (2014) Marta Sowinska et al. NEW JOURNAL OF CHEMISTRY
- Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer
- (2014) Bo Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New HER2-Positive Targeting Agents in Clinical Practice
- (2014) Sara Tolaney Current Oncology Reports
- Dendrimers: synthesis, applications, and properties
- (2014) Elham Abbasi et al. Nanoscale Research Letters
- Breast cancer as a systemic disease: a view of metastasis
- (2013) A. J. Redig et al. JOURNAL OF INTERNAL MEDICINE
- Trends in Translational Medicine and Drug Targeting and Delivery: New Insights on an Old Concept—Targeted Drug Delivery with Antibody–Drug Conjugates for Cancers
- (2013) J.Y. Rodney et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Emerging Research and Clinical Development Trends of Liposome and Lipid Nanoparticle Drug Delivery Systems
- (2013) John C. Kraft et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Biomarkers of Residual Disease, Disseminated Tumor Cells, and Metastases in the MMTV-PyMT Breast Cancer Model
- (2013) Christian Franci et al. PLoS One
- Quantum dots as a platform for nanoparticle drug delivery vehicle design
- (2012) Christine E. Probst et al. ADVANCED DRUG DELIVERY REVIEWS
- Arginine functionalized peptide dendrimers as potential gene delivery vehicles
- (2012) Kui Luo et al. BIOMATERIALS
- Progesterone Receptor Isoform Functions in Normal Breast Development and Breast Cancer
- (2012) Anastasia Kariagina et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Metal-organic frameworks as potential drug delivery systems
- (2012) Chun-Yi Sun et al. Expert Opinion on Drug Delivery
- Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study
- (2012) Kimberly L. Blackwell et al. JOURNAL OF CLINICAL ONCOLOGY
- Physiologically Based Pharmacokinetic Model for Composite Nanodevices: Effect of Charge and Size on In Vivo Disposition
- (2012) Donald E. Mager et al. PHARMACEUTICAL RESEARCH
- Biologically Optimized Nanosized Molecules and Particles: More than Just Size
- (2011) Michelle R. Longmire et al. BIOCONJUGATE CHEMISTRY
- Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increasedin vivoactivity
- (2011) Jerzy Gubernator Expert Opinion on Drug Delivery
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Review of an Unfavorable Subset of Breast Cancer: Estrogen Receptor Positive Progesterone Receptor Negative
- (2011) J. P. Thakkar et al. ONCOLOGIST
- Mechanisms of Anthracycline Cardiotoxicity and Strategies to Decrease Cardiac Damage
- (2010) Carrie Anna Geisberg et al. CURRENT HYPERTENSION REPORTS
- The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer
- (2010) Donald P McDonnell et al. CURRENT OPINION IN PHARMACOLOGY
- The molecular pathology of breast cancer progression
- (2010) Alessandro Bombonati et al. JOURNAL OF PATHOLOGY
- Combinatorial Drug Conjugation Enables Nanoparticle Dual-Drug Delivery
- (2010) Santosh Aryal et al. Small
- Toxicity of therapeutic nanoparticles
- (2009) Melissa A Maurer-Jones et al. Nanomedicine
- Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance
- (2008) Grazia Arpino et al. ENDOCRINE REVIEWS
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy
- (2008) Paul Tardi et al. LEUKEMIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More